Citations 2
Estimated VESALIUS-Like Eligibility and Projected Cardiovascular Benefit in US Adults
Ibrahim, Ramzi , Zanco, Julia , Serra, Vinicius De Sousa Barzon , Ayoub, Chadi , Arsanjani, Reza, Al‐Kindi, Sadeer , Barzon Serra, Vinicius De Sousa, Ibrahim, Ramzi , Ayoub, Chadi , Arsanjani, Reza
European Heart Journal - Quality of Care and Clinical Outcomes | August 14, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available
Pericardial Effusion and Bruton Tyrosine Kinase Inhibitors in B-Cell Malignant Disease
Zanco, Julia , Ibrahim, Ramzi, Pham, Hoang Nhat, Farina, Juan M., Narayanasamy, Hema, Tamarappoo, Balaji , Herrmann, Joerg, Ayoub, Chadi, Arsanjani, Reza, Larsen, Carolyn M , Ibrahim, Ramzi , Pham, Hoang Nhat , Farina, Juan M., Larsen, Carolyn , Herrmann, Joerg , Arsanjani, Reza
JAMA Oncology | February 19, 2026 | Volume: 12 | Issue: 4 | Pages: 419
This cohort study examines the association of bruton tyrosine kinase inhibitor therapy in B-cell malignant disease with increased risk of pericardial effusion and cardiovascular outcomes.